130 related articles for article (PubMed ID: 37752678)
41. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD
JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397
[TBL] [Abstract][Full Text] [Related]
42. Uptake of testing for germline
Stearnes G; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Cohen PA
Int J Gynecol Cancer; 2019 Jul; 29(6):1038-1042. PubMed ID: 31101686
[TBL] [Abstract][Full Text] [Related]
43. Decision aids for people facing health treatment or screening decisions.
O'Connor AM; Bennett CL; Stacey D; Barry M; Col NF; Eden KB; Entwistle VA; Fiset V; Holmes-Rovner M; Khangura S; Llewellyn-Thomas H; Rovner D
Cochrane Database Syst Rev; 2009 Jul; (3):CD001431. PubMed ID: 19588325
[TBL] [Abstract][Full Text] [Related]
44. Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis.
Lin J; Sharaf RN; Saganty R; Ahsan D; Feit J; Khoury A; Bergeron H; Chapman-Davis E; Cantillo E; Holcomb K; Blank SV; Liu Y; Thomas C; Christos PJ; Wright DN; Lipkin S; Offit K; Frey MK
Gynecol Oncol; 2021 Aug; 162(2):506-516. PubMed ID: 34023131
[TBL] [Abstract][Full Text] [Related]
45. Developing a patient decision aid for women aged 70 and older with early stage, estrogen receptor positive, HER2 negative, breast cancer.
Schonberg MA; Freedman RA; Recht AR; Jacobson AR; Aliberti GM; Karamourtopoulos M; Nakhlis F; McCarthy EP; Pories SE; Sharma R; Dominici LS
J Geriatr Oncol; 2019 Nov; 10(6):980-986. PubMed ID: 31130442
[TBL] [Abstract][Full Text] [Related]
46. Quality and effectiveness of osteoporosis treatment decision aids: a systematic review and environmental scan.
Paskins Z; Torres Roldan VD; Hawarden AW; Bullock L; Meritxell Urtecho S; Torres GF; Morera L; Espinoza Suarez NR; Worrall A; Blackburn S; Chapman S; Jinks C; Brito JP
Osteoporos Int; 2020 Oct; 31(10):1837-1851. PubMed ID: 32500301
[TBL] [Abstract][Full Text] [Related]
47. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
[TBL] [Abstract][Full Text] [Related]
48. Comparison of the Effects of a Pharmaceutical Industry Decision Guide and Decision Aids on Patient Choice to Intensify Therapy in Rheumatoid Arthritis.
Martin RW; Enck RD; Tellinghuisen DJ; Eggebeen AT; Birmingham JD; Head AJ
Med Decis Making; 2017 Jul; 37(5):577-588. PubMed ID: 28590834
[TBL] [Abstract][Full Text] [Related]
49. Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.
Manchanda R; Patel S; Gordeev VS; Antoniou AC; Smith S; Lee A; Hopper JL; MacInnis RJ; Turnbull C; Ramus SJ; Gayther SA; Pharoah PDP; Menon U; Jacobs I; Legood R
J Natl Cancer Inst; 2018 Jul; 110(7):714-725. PubMed ID: 29361001
[TBL] [Abstract][Full Text] [Related]
50. Attitudes towards a programme of risk assessment and stratified management for ovarian cancer: a focus group study of UK South Asians' perspectives.
Hann KEJ; Ali N; Gessler S; Fraser LSM; Side L; Waller J; Sanderson SC; Lanceley A;
BMJ Open; 2018 Jul; 8(7):e021782. PubMed ID: 30021754
[TBL] [Abstract][Full Text] [Related]
51. Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.
Eccles DM; Balmaña J; Clune J; Ehlken B; Gohlke A; Hirst C; Potter D; Schroeder C; Tyczynski JE; Gomez Garcia EB
Adv Ther; 2016 Feb; 33(2):129-50. PubMed ID: 26809252
[TBL] [Abstract][Full Text] [Related]
52. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
[TBL] [Abstract][Full Text] [Related]
53. Decision Aids Can Support Cancer Clinical Trials Decisions: Results of a Randomized Trial.
Politi MC; Kuzemchak MD; Kaphingst KA; Perkins H; Liu J; Byrne MM
Oncologist; 2016 Dec; 21(12):1461-1470. PubMed ID: 27511904
[TBL] [Abstract][Full Text] [Related]
54. Decision aids for second-line palliative chemotherapy: a randomised phase II multicentre trial.
Oostendorp LJM; Ottevanger PB; Donders ART; van de Wouw AJ; Schoenaker IJH; Smilde TJ; van der Graaf WTA; Stalmeier PFM
BMC Med Inform Decis Mak; 2017 Aug; 17(1):130. PubMed ID: 28859646
[TBL] [Abstract][Full Text] [Related]
55. Interactivity in a Decision Aid: Findings From a Decision Aid to Technologically Enhance Shared Decision Making RCT.
Jimbo M; Sen A; Plegue MA; Hawley S; Kelly-Blake K; Rapai M; Zhang M; Zhang Y; Xie X; Ruffin MT
Am J Prev Med; 2019 Jul; 57(1):77-86. PubMed ID: 31128959
[TBL] [Abstract][Full Text] [Related]
56. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
57. Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy.
Ager B; Jansen J; Porter D; Phillips KA; Glassey R; ; Butow P
Breast; 2018 Aug; 40():156-164. PubMed ID: 29857282
[TBL] [Abstract][Full Text] [Related]
58. The sooner the better: Genetic testing following ovarian cancer diagnosis.
Fox E; McCuaig J; Demsky R; Shuman C; Chitayat D; Maganti M; Murphy J; Rosen B; Ferguson S; Randall Armel S
Gynecol Oncol; 2015 Jun; 137(3):423-9. PubMed ID: 25868966
[TBL] [Abstract][Full Text] [Related]
59. Modified panel-based genetic counseling for ovarian cancer susceptibility: A randomized non-inferiority study.
McCuaig JM; Tone AA; Maganti M; Romagnuolo T; Ricker N; Shuldiner J; Rodin G; Stockley T; Kim RH; Bernardini MQ
Gynecol Oncol; 2019 Apr; 153(1):108-115. PubMed ID: 30638766
[TBL] [Abstract][Full Text] [Related]
60. Interactive patient decision aids for women facing genetic testing for familial breast cancer: a systematic web and literature review.
Williams L; Jones W; Elwyn G; Edwards A
J Eval Clin Pract; 2008 Feb; 14(1):70-4. PubMed ID: 18211647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
